Beekeepers in Florida need state funding to maintain healthy population of Honey Bees

Beekeepers in Florida said that they need state funding and some help to maintain healthy population of honey bees. As per the Florida State Beekeepers Association, it needs $3.5 million for an apiary research center at the University of Florida.

According to the state's beekeepers, honey bees play an important role in agriculture and the economy. The state is the third largest honey-producing state in the United States. Florida reported crop value of $22.7 million in 2013.

About a decade ago, Florida had just 1,200 beekeepers, but now, the state in the southeastern region of the United States has approximately 3,500 beekeepers. The state's 400,000 honey-producing bee colonies face several kinds of threats including parasite called varroa mites.

Environmental Group asks for Investigation into Climate-change Terms’ ban in Florida

Earlier, some environmental scientists in Florida said that their supervisors ordered them not to use terms 'climate change' and 'global warming' in their work. According to Florida governor Rick Scott, his administration did not ban environmental scientists from using the terms.

Now, an environmental group have requested for a state investigation to know more about the ban. On Tuesday, members of the group Forecast the Facts filed complaint with the Department of Environmental Protection's inspector-general. They urged the department to find the truth about the report.

Doctors release Baby who was rescued from Icy Utah River

Doctors have permitted a Utah toddler to leave hospital after she was rescued from a car 14 hours after it crashed into a frigid river. The permission for the release was granted on Wednesday, days after the accident that claimed the life of her mother.

"I came in, I put my finger in her hand, and I told her 'dad is here' and I loved her. She squeezed my hand and then a few hours later she tried to open her eyes. I haven't left her bedside since", said the girl's father Deven Trafny, 34.

At about 4pm, 18-month-old Lily Groesbeck was released from Lily Groesbeck, said spokeswoman Bonnie Midget. The girl is doing fine now apart from a few bruises. She is facing no trouble and is able to play and talk. She was reciting nursery rhymes, said Trafny.

Two Police Officers shot outside Ferguson Police Department

Acting Ferguson police chief Lt. Col. Al Eickhoff said bullet injuries have been caused to two St. Louis County Police officers after they were shot outside the Ferguson Police Department early Thursday. The two police officers were immediately taken to hospital in ambulances, said Bob Hoehn, a KSDK-TV photographer.

One was admitted into Barnes-Jewish Hospital, a Level 1 trauma center and the teaching hospital for Washington University School of Medicine. Treatment was provided to the other officer on the crime scene itself.

While giving update about the health condition of the two officers during a press conference around 2 am, St. Louis County Police Chief Jon Belmar said one officer was shot in the shoulder, and the other in the face.

Schneiderman’s office is heading coalition of state attorneys general to expand examination of supplements industry

It has been informed that improvement has been seen in the stocks of supplements retailers The Vitamin Shoppe and GNC Holdings. The Vitamin Shoppe is a New Jersey-based retailer of nutritional supplements and GNC Holdings is a commercial enterprise that is concentrated on the retail sale of health and nutrition-related products, involving vitamins and supplements.

An announcement has been made by New York Attorney General Eric Schneiderman that his office is heading an alliance of state attorneys general to increase his assessment of the industry so that transparency can be improved and also to make sure that the products really contain what their labels claim to contain, and nothing more.

Kythera Biopharmaceutical’s Drug ATX-101 Very Close to FDA’s approval

It has been reported that an injection developed by Kythera Biopharmaceutical Inc to get rid of double chin was backed by an independent panel of experts on Monday.

Stock of the biopharmaceutical company has tripled since it went public in 2012. Investors bet that the company's drugs can be the first ever drug approved in the United States to reduce localized fat deposits.

FDA's acceptance of recommendations given by the panel has brought the drug, ATX-101, closer to approval by the agency.

The drug, ATX-101, is a formulation of synthetically derived deoxycholic acid, which helps to destroy the fat that gets collected under the chin. The positive feature about the drug is that it destroys the fats without affecting the surrounding tissues.

Pages

News in Focus

KPIT Technologies Share Price Target at Rs 1,475: ICICI Direct

ICICI Direct has reiterated its BUY call on KPIT Technologies, projecting a 12‑month target price of Rs 1,475 versus a current market price of Rs 1,223, implying upside potential of about 21 percen

Lodha Developers Share Price Target at Rs 1,888: Motilal Oswal

Motilal Oswal Financial Services has reiterated a BUY rating on Lodha Developers, calling for an aggressive re-rating as the country’s largest listed real estate player cements its dominance in Mum

Delhi's Hottest SUV: A Buyer's Checklist for Evaluating Used Creta Cars

The Hyundai Creta quickly became a massive success, and its popularity is just as strong in the 2nd hand cars market in Delhi.

Vishal Mega Mart (VMM) Share Price Target at Rs 180: Emkay Global Research

Emkay Global Financial Services Limited has issued a BUY recommendation for Vishal Mega Mart (VMM), setting an ambitious target price of Rs 180 against the current market price of Rs 136, implying

TCS Share Price Target at Rs 3,565: Axis Securities

Axis Securities has issued a compelling BUY recommendation for Tata Consultancy Services (TCS), positioning the IT services behemoth as a transformative force in the artificial intelligence era.

Bajaj Finance Share Price Target at Rs 1,180: ICICI Securities

ICICI Securities has upgraded Bajaj Finance to a BUY rating, revising its target price upward to Rs 1,180 from Rs 1,040, implying an 18% upside from the current market price of Rs